LBEL REGRESSION JOURProtective Complex with SPF 15 Facial day normal to dry skin (Ventura Corporation Ltd.)
Welcome to the PulseAid listing for the LBEL REGRESSION JOUR drug offered from Ventura Corporation Ltd.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Ventura Corporation Ltd. |
NON-PROPRIETARY NAME: | Avobenzone, Ensulizole, Octinoxate, and Oxybenzone |
SUBSTANCE NAME: | AVOBENZONE; ENSULIZOLE; OCTINOXATE; OXYBENZONE |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | TOPICAL |
DOSAGE FORM: | CREAM |
MARKETING CATEGORY NAME: | OTC MONOGRAPH NOT FINAL |
START MARKETING DATE: | 2012-05-14 |
END MARKETING DATE: | 0000-00-00 |
LBEL REGRESSION JOUR Protective Complex with SPF 15 Facial day normal to dry skin HUMAN OTC DRUG Details:
Item Description | LBEL REGRESSION JOUR Protective Complex with SPF 15 Facial day normal to dry skin from Ventura Corporation Ltd. |
LABELER NAME: | Ventura Corporation Ltd. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | .02; .01; .075; .02(g/g; g/g; g/g; g/g) |
START MARKETING DATE: | 2012-05-14 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 13537-025_ac565e8f-4ea5-4a81-a24d-eaff466a0301 |
PRODUCT NDC: | 13537-025 |
APPLICATION NUMBER: | part352 |
Other AVOBENZONE; ENSULIZOLE; OCTINOXATE; OXYBENZONE Pharmaceutical Manufacturers / Labelers: